Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Octreotide 84-mg Subcutaneous Hydrogel Implant Prot # EN3332-301: Phase IIIB, Open- Label, Multicenter Study to Evaluate the Long Term Safety and Efficacy of an 84MG Octreotide Subcutaneous Hydrogel Implant in Subjects with Acromegaly
Molitch, Mark E
(PD/PI)
Medicine, Endocrinology Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
2/15/11
→
2/15/13
Funding
Endo Pharmaceuticals Inc.
(EN3332-301)
View all
View less